RxDoctor Payments Data

Kenan Kirkendall, DO

Family Medicine · Woodward, OKNPI 1316949563

Payments from drug & device makers

$8,369in general payments, 2019–2025

Across 10 payments — averaging $836.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Thermo Fisher Scientific Asheville LLC$7K
  • GE HealthCare$699
  • AstraZeneca$102
  • AbbVie$65
  • Mannkind Corporation$43
  • Amgen$32
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$1992%
  • Education$541%
  • Gifts$7,41789%
  • Other$6998%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Thermo Fisher Scientific Asheville LLC1$7,417
GE HealthCare1$699
AstraZeneca1$102
AbbVie3$65
Mannkind Corporation1$43
Amgen2$32
Lilly USA, LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,369 in reported general payments places this provider in the 90th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$917,803
Medicare patients
1,003
Services billed
28,106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide332$352,776
EliquisApixaban330$206,346
OzempicSemaglutide154$152,681
JardianceEmpagliflozin182$151,085
TrulicityDulaglutide135$139,216
FarxigaDapagliflozin Propanediol100$91,274
JanuviaSitagliptin Phosphate99$78,215
XareltoRivaroxaban119$74,566
Breztri AerosphereBudesonide/Glycopyr/Formoterol53$40,688
Repatha SureclickEvolocumab55$33,917
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$30,490
JanumetSitagliptin Phos/Metformin Hcl35$29,064
GlyxambiEmpagliflozin/Linagliptin35$28,788
Janumet XrSitagliptin Phos/Metformin Hcl26$18,403
VascepaIcosapent Ethyl33$17,190

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$12$491,992467 claims
AstraZenecaFarxiga, Breztri Aerosphere$102$131,962153 claims
AbbVieQulipta$65$12,63622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Woodward

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →